Cargando…
Refractory dermatitis contributed by pityriasis versicolor: a case report
BACKGROUND: Dermatologic toxicity is a very common immune-related adverse event (irAE) for patients with melanoma who are receiving immune checkpoint inhibitor therapy (ICI). Concurrent skin infection, such as in the case of pityriasis versicolor reported here, can mimic and/or exacerbate dermatolog...
Autores principales: | Li, Mingjia, Spaccarelli, Natalie, Kendra, Kari, Wu, Richard C., Verschraegen, Claire |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063482/ https://www.ncbi.nlm.nih.gov/pubmed/33888150 http://dx.doi.org/10.1186/s13256-021-02818-1 |
Ejemplares similares
-
Pityriasis Versicolor
Publicado: (1901) -
Infantile hypopigmented pityriasis versicolor: two uncommon cases
por: Abdollahimajd, Fahimeh, et al.
Publicado: (2019) -
Confluent and Reticulated Papillomatosis Resembling Pityriasis Versicolor and Acanthosis Nigricans: Case Report
por: David, Abhinav, et al.
Publicado: (2023) -
A case of anti- pityriasis versicolor therapy that preserves healthy mycobiome
por: Dyląg, Mariusz, et al.
Publicado: (2020) -
Antifungal Treatment for Pityriasis Versicolor
por: Gupta, Aditya K., et al.
Publicado: (2015)